With a team consisting of solicitors and patent lawyers, Maiwald GmbH is a one-stop patent shop and also provides seamless advice on other IP areas, including trade mark and copyright law. The group's technical cornerstones include engineering, medical technology, biotechnology as well as chemistry and pharmaceuticals, while its geographical focus rests on the US, China, Switzerland and the United Kingdom. Eva Ehlich (polymer chemistry, drug delivery, formulation technology), Dirk Bühler (drugs, molecular chemistry, biology, diagnostics) and Derk Vos (chemistry and pharmacy) are among the team's key contacts.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Excellent understanding of technology and business, very professional modus operandi, excellent lawyers with a high level of competence.'

  • 'Alexander Schmitz: Outstanding patent attorney with outstanding expertise in the areas of physics/mechanics/electrical engineering/software/algorithms.'
  • 'What is special is their technology-oriented handling of matters, without having to excessively deal with formal issues.'

  • 'Partners at eye level, patent issues are always viewed against the background of our business and research development. We know that Maiwald's advice does not come from an external consultant, but from someone who puts themselves in our shoes.'

  • 'Andreas Ledl and Eva Dörner are not only top-class experts, but also have a particular instinct for the employees involved.'

  • 'The team is very well organised, very responsive and always of very good quality.'

  • 'Very good understanding of legal trends, very good advice.'

  • 'Very good, sound and at the same time pragmatic advice. Derk Vos has extremely good industry knowledge, knows all current international parallel and ECJ proceedings and is very well connected. His responsiveness combined with excellent thematic quality is impressive. It is a great pleasure to work with him.'

Key clients

  • ABB AG
  • Acadia Pharmaceuticals
  • Biotheryx
  • Borealis
  • Brainlab AG
  • CureVac AG
  • Formycon/ bioeq
  • Fraunhofer
  • Gedeon Richter
  • Heraeus
  • Numaferm
  • PepsiCo
  • Proxygen
  • Reebok International Ltd.
  • Spectroplast
  • United States of America, as represented by the Secretary - Department of Health and Human Services
  • Unity Biotechnology Inc.
  • United Grinding and related company IRPD
  • VEGA Grieshaber KG
  • Volvocar

Work highlights

  • Advising CureVac AG on RNA-based medicines (including production and medical use).
  • Advising Borealis on its global patent portfolio.

Other key lawyers

Eva Dörner, Andreas Ledl, Christian Pioch, Alexander Ortlieb, Alexander Schmitz, Lutz Kietzmann, Dirk Bühler, Martin Huenges, Angela Zumstein, Eva Ehlich, Sophie Ertl, Naho Fujimoto, Christian Schäflein, Annelie Wünsche, Derk Vos